Last update 20 Mar 2025

Teriparatide biosimilar(Sun Pharmaceutical Industries Ltd.)

Overview

Basic Info

Drug Type
Recombinant polypeptide, Biosimilar
Synonyms
Bonista, Osteotide, Teriparatide biosimilar
+ [2]
Target
Action
agonists, stimulants
Mechanism
PTH1R agonists(Parathyroid hormone receptor agonists), Osteogenesis stimulants, Parathyroid hormone replacements
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Primary osteoporosis
Australia
02 May 2024
Glucocorticoid-induced osteoporosis
Liechtenstein
18 Nov 2022
Glucocorticoid-induced osteoporosis
Norway
18 Nov 2022
Glucocorticoid-induced osteoporosis
European Union
18 Nov 2022
Glucocorticoid-induced osteoporosis
Iceland
18 Nov 2022
Osteoporosis, Postmenopausal
European Union
18 Nov 2022
Osteoporosis, Postmenopausal
Iceland
18 Nov 2022
Osteoporosis, Postmenopausal
Norway
18 Nov 2022
Osteoporosis, Postmenopausal
Liechtenstein
18 Nov 2022
Osteoporotic Fractures
Liechtenstein
18 Nov 2022
Osteoporotic Fractures
Norway
18 Nov 2022
Osteoporotic Fractures
Iceland
18 Nov 2022
Osteoporotic Fractures
European Union
18 Nov 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free